CRP and major depressive disorder: Additionally, our exploratory objective will examine blood biomarkers that are mechanistically related to psilocybin and/or MDD including those involved with increased neurogenesis and neuroplasticity (BDNF), glial pathology (S100B), and systemic inflammation (CRP).